Page last updated: 2024-08-21

quinazolines and Enlarged Spleen

quinazolines has been researched along with Enlarged Spleen in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aksu, S; Büyükaşık, Y; Eliaçık, E; Göker, H; Haznedaroğlu, İC; Işık, A; Özcebe, OI; Sayınalp, N; Üner, A1
Alkindi, S; Dennison, D; Pathare, A1
Alferez, D; Goodlad, RA; Mandir, N; Poulsom, R; Pyrah, IT; Ryan, AJ; Smith, NR; Watkins, AJ; Wedge, SR; Wilkinson, RW1
Liu, D; Seiter, K; Yalamanchili, K1
Bennett, M; Chubar, E1

Reviews

1 review(s) available for quinazolines and Enlarged Spleen

ArticleYear
Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2015, Volume: 32, Issue:2

    Topics: Bone Marrow; Combined Modality Therapy; Disease Progression; Female; Fibrosis; Humans; Hydroxyurea; Janus Kinase 2; Leukapheresis; Middle Aged; Myeloproliferative Disorders; Nitriles; Phlebotomy; Point Mutation; Polycythemia Vera; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinazolines; Splenectomy; Splenomegaly

2015

Other Studies

4 other study(ies) available for quinazolines and Enlarged Spleen

ArticleYear
Successful outcome with anagrelide in pregnancy.
    Annals of hematology, 2005, Volume: 84, Issue:11

    Topics: Adult; Blood Cell Count; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Quinazolines; Splenomegaly; Thrombocytosis

2005
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
    Carcinogenesis, 2006, Volume: 27, Issue:10

    Topics: Adenoma; Animals; Female; Genes, APC; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Quinazolines; RNA, Messenger; Signal Transduction; Splenomegaly; Vascular Endothelial Growth Factor Receptor-2

2006
Myelofibrosis with a novel translocation, t(1;3)(q31;q23), and response to imatinib mesylate.
    Leukemia, 2007, Volume: 21, Issue:3

    Topics: Antigens, CD; Benzamides; Bone Marrow Cells; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 3; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Primary Myelofibrosis; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Remission Induction; Splenomegaly; Translocation, Genetic

2007
Chronic myeloid leukemia evolving after idiopathic myelofibrosis.
    The Israel Medical Association journal : IMAJ, 2007, Volume: 9, Issue:7

    Topics: Adult; Blood Cell Count; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Fibrinolytic Agents; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Male; Megakaryocytes; Primary Myelofibrosis; Quinazolines; Splenomegaly; Thrombocytopenia; Translocation, Genetic

2007